Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.95 |
| ▸ | CES2 | O00748 | 1/20 | 0.65 |
| ▸ | CES1 | P23141 | 1/20 | 0.65 |
| ▸ | TSHR | P16473 | 2/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.62 |
| ▸ | POLB | P06746 | 2/20 | 0.58 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.53 |
| ▸ | FEN1 | P39748 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 4/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.52 |
| ▸ | CA4 | P22748 | 1/20 | 0.52 |
| ▸ | CA6 | P23280 | 1/20 | 0.52 |
| ▸ | CA7 | P43166 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8482425 | 0.97 | ALDH1A1 (1.00) | ALDH1A1CES2CES1TSHRALOX15 | |
| SCHEMBL29369803 | 0.97 | ALDH1A1 (1.00) | ALDH1A1CES2CES1TSHRALOX15 | |
| SCHEMBL29004189 | 0.97 | ALDH1A1 (1.00) | ALDH1A1CES2CES1TSHRALOX15 | |
| SCHEMBL29518925 | 0.97 | ALDH1A1 (1.00) | ALDH1A1CES2CES1TSHRALOX15 | |
| SCHEMBL367 | 0.97 | ALDH1A1 (1.00) | ALDH1A1CES2CES1TSHRALOX15 | |
| SCHEMBL431318 | 0.95 | ALDH1A1 (0.95) | ALDH1A1CES2CES1TSHRALOX15 | |
| Hydrochloric Acid SCHEMBL784866 | 0.95 | ALDH1A1 (0.95) | ALDH1A1CES2CES1TSHRALOX15 | |
| SCHEMBL6915177 | 0.95 | ALDH1A1 (0.95) | ALDH1A1CES2CES1TSHRALOX15 | |
| SCHEMBL8747321 | 0.95 | ALDH1A1 (0.95) | ALDH1A1CES2CES1TSHRALOX15 | |
| SCHEMBL6913277 | 0.95 | ALDH1A1 (0.95) | ALDH1A1CES2CES1TSHRALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4724443-A1 | PYRAZOLO-PYRIMIDINONE COMPOUNDS FOR USE IN METHODS OF INHIBITING WEE1 A KINASE | Acrivon Therapeutics, Inc. (US) | 2026-04-15 | — | — | EP | disclosed |
| EP-3710422-B1 | PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY AND DIASTEREOMERICALLY ENRICHED CYCLOBUTANE AMINES AND AMIDES | SYNGENTA CROP PROTECTION AG (CH) | 2026-01-07 | — | — | EP | disclosed |
| WO-2024254490-A1 | PYRAZOLO-PYRIMIDINONE COMPOUNDS FOR USE IN METHODS OF INHIBITING WEE1 A KINASE | ACRIVON THERAPEUTICS, INC. (US) | 2024-12-12 | — | — | WO | disclosed |
| CN-221108213-U | O-chlorobenzonitrile production equipment | 莘县正升化工有限公司 | 2024-06-11 | — | — | CN | disclosed |
| CN-110423207-B | Synthesis method of o-chlorobenzonitrile | 三门峡环宇生化科技有限公司 | 2022-08-12 | — | — | CN | disclosed |
| CN-110467543-B | Preparation method of o-chlorobenzonitrile | 三门峡环宇生化科技有限公司 | 2022-06-07 | — | — | CN | disclosed |
| CN-215440106-U | Spices and essence effluent disposal system | 江苏善鼎环保科技有限公司 | 2022-01-07 | — | — | CN | disclosed |
| US-11053188-B2 | Process for the preparation of enantiomerically and diastereomerically enriched cyclobutane amines and amides | SYNGENTA PARTICIPATIONS AG (CH) | 2021-07-06 | — | — | US | disclosed |
| US-20200407311-A1 | PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY AND DIASTEREOMERICALLY ENRICHED CYCLOBUTANE AMINES AND AMIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2020-12-31 | — | — | US | disclosed |
| CN-110437101-A | A kind of pair of 6-chlorophenyl nitrile, the preparation method to chlorobenzamide | SANMENXIA HUANYU BIOCHEMICAL TECH CO LTD | 2019-11-12 | — | — | CN | disclosed |
| CN-110396056-A | A method of preparing m-chlorobenzene nitrile | SANMENXIA HUANYU BIOCHEMICAL TECH CO LTD | 2019-11-01 | — | — | CN | disclosed |
| CN-101316810-A | Ionic liquids | BIONIQS LTD (GB) | 2008-12-03 | — | — | CN | disclosed |
| EP-0770103-B1 | LOW VOC REFINISH COATING COMPOSITION | DU PONT (US) | 2002-03-27 | — | — | EP | disclosed |
| EP-0770103-A1 | LOW VOC REFINISH COATING COMPOSITION | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1997-05-02 | — | — | EP | disclosed |
| WO-1996001864-A1 | LOW VOC REFINISH COATING COMPOSITION | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-01-25 | — | — | WO | disclosed |
| WO-1993000377-A1 | LOW VOLATILE ORGANIC CONTENT CLEAR EPOXY ACRYLIC COATING COMPOSITION FOR BASECOAT CLEAR COAT FINISH | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-01-07 | — | — | WO | disclosed |
| US-5084542-A | Clear colorless resistant coatings with improved weatherability | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-01-28 | — | — | US | disclosed |
| WO-1991018937-A1 | EPOXY/ISOCYANATE CROSSLINKED COATINGS CONTAINING 1,3-DISUBSTITUTED IMIDAZOLE-2-THIONE CATALYSTS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-12-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200407311-A1 | PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY AND DIASTEREOMERICALLY ENRICHED CYCLOBUTANE AMINES AND AMIDES | TBCB, ADORA2B, ADRA2B | ALDH1A1 955/4885CES2 600/4885CES1 1136/4885 |
| US-11053188-B2 | Process for the preparation of enantiomerically and diastereomerically enriched cyclobutane amines and amides | TBCB, ADORA2B, CCNB3 | ALDH1A1 979/4885CES2 601/4885CES1 1268/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.